{"id":7909,"date":"2024-12-18T18:51:47","date_gmt":"2024-12-18T10:51:47","guid":{"rendered":"https:\/\/regask.com\/?p=7909"},"modified":"2024-12-18T18:51:47","modified_gmt":"2024-12-18T10:51:47","slug":"%e3%83%91%e3%83%a9%e3%82%b0%e3%82%a2%e3%82%a4-%e3%83%87%e3%82%a3%e3%83%8a%e3%83%93%e3%82%b5%e5%8c%bb%e8%96%ac%e5%93%81%e6%89%bf%e8%aa%8d%e3%82%ac%e3%82%a4%e3%83%89%e3%83%a9%e3%82%a4%e3%83%b3","status":"publish","type":"post","link":"https:\/\/regask.com\/ja\/paraguay-dinavisa-drug-approval-guideline\/","title":{"rendered":"DINAVISA (\u30d1\u30e9\u30b0\u30a2\u30a4) \u304c\u512a\u826f\u8f38\u51fa\u5165\u306b\u95a2\u3059\u308b\u65b0\u3057\u3044\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u627f\u8a8d"},"content":{"rendered":"<p>2024\u5e7412\u67082\u65e5\u3001 <a href=\"https:\/\/regask.com\/ja\/%e3%83%91%e3%83%a9%e3%82%b0%e3%82%a2%e3%82%a4%e3%81%ae%e4%b9%b3%e7%b3%96%e4%b8%8d%e4%bd%bf%e7%94%a8%e9%a3%9f%e5%93%81%e8%a6%8f%e5%88%b6\/\">\u56fd\u5bb6\u885b\u751f\u76e3\u8996\u5c40<\/a> \uff08DINAVISA\uff09\u306f\u3001 <strong>\u300c\u533b\u85ac\u54c1\u306e\u767b\u9332\u306e\u305f\u3081\u306e\u9069\u6b63\u8a55\u4fa1\u57fa\u6e96\u30ac\u30a4\u30c9\u300d<\/strong> \u3053\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306f\u3001\u898f\u5236\u67a0\u7d44\u307f\u306e\u5927\u5e45\u306a\u66f4\u65b0\u3067\u3042\u308a\u3001\u660e\u78ba\u3067\u900f\u660e\u306a\u8a55\u4fa1\u30d7\u30ed\u30bb\u30b9\u3092\u901a\u3058\u3066\u533b\u85ac\u54c1\u306e\u54c1\u8cea\u3001\u5b89\u5168\u6027\u3001\u6709\u52b9\u6027\u3092\u78ba\u4fdd\u3059\u308b\u3053\u3068\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u30ac\u30a4\u30c9\u306f\u3001DINAVISA \u306e\u624b\u9806\u3092\u56fd\u969b\u57fa\u6e96\u306b\u5408\u308f\u305b\u3001\u4e16\u754c\u306e\u898f\u5236\u57fa\u6e96\u3068\u306e\u8abf\u548c\u3092\u4fc3\u9032\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30ac\u30a4\u30c9\u306f\u3001\u533b\u85ac\u54c1\u3001\u751f\u7269\u88fd\u5264\u3001\u5316\u5b66\u85ac\u54c1\u3001\u8a66\u85ac\u3001\u533b\u7642\u6a5f\u5668\u3001\u5316\u7ca7\u54c1\u307e\u305f\u306f\u6d88\u6bd2\u5264\u306b\u5206\u985e\u3055\u308c\u308b\u500b\u4eba\u885b\u751f\u7528\u54c1\u306a\u3069\u3001\u4eba\u4f53\u3078\u306e\u4f7f\u7528\u3092\u76ee\u7684\u3068\u3057\u305f\u3059\u3079\u3066\u306e\u533b\u85ac\u54c1\u306b\u9069\u7528\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306e\u4e3b\u306a\u30cf\u30a4\u30e9\u30a4\u30c8\u306f\u6b21\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li>\u9075\u5b88 <strong>\u56fd\u969b\u57fa\u6e96<\/strong> \u533b\u85ac\u54c1\u8a55\u4fa1\u306e\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u3002<\/li>\n<li>\u524d\u81e8\u5e8a\u8a66\u9a13\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u627f\u8a8d\u3001\u5e02\u8ca9\u5f8c\u306e\u5909\u66f4\u3001\u518d\u767b\u9332\u30d7\u30ed\u30bb\u30b9\u306a\u3069\u3001\u88fd\u54c1\u958b\u767a\u306e\u3042\u3089\u3086\u308b\u6bb5\u968e\u306b\u304a\u3051\u308b\u8a73\u7d30\u306a\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u8981\u4ef6\u3002<\/li>\n<li>\u5f37\u8abf\u3059\u308b <strong>\u591a\u5206\u91ce\u306b\u308f\u305f\u308b\u30a2\u30d7\u30ed\u30fc\u30c1<\/strong> \u975e\u81e8\u5e8a\u3001\u81e8\u5e8a\u3001\u751f\u4f53\u9069\u5408\u6027\u3001\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u3001\u30ea\u30b9\u30af\u7ba1\u7406\u306e\u8a55\u4fa1\u3092\u7d71\u5408\u3057\u307e\u3059\u3002<\/li>\n<li>\u8a8d\u5b9a\u3055\u308c\u305f\u5c02\u9580\u5bb6\u306b\u3088\u308b\u8a55\u4fa1\u3092\u6d3b\u7528\u3059\u308b\u4ed5\u7d44\u307f <strong>\u56fd\u969b\u898f\u5236\u5f53\u5c40<\/strong> \u53b3\u683c\u306a\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u306e\u57fa\u6e96\u3092\u7dad\u6301\u3057\u306a\u304c\u3089\u5be9\u67fb\u3092\u8fc5\u901f\u5316\u3057\u307e\u3059\u3002<\/li>\n<li>\u80b2\u6210\u306b\u91cd\u70b9\u3092\u7f6e\u304f <strong>\u7d99\u7d9a\u7684\u306a\u5c02\u9580\u80fd\u529b\u958b\u767a<\/strong> \u8a55\u4fa1\u8005\u9593\u306e\u6279\u5224\u7684\u601d\u8003\u3092\u4fc3\u9032\u3057\u3001\u6700\u65b0\u306e\u79d1\u5b66\u7684\u7406\u89e3\u306b\u57fa\u3065\u3044\u305f\u8a3c\u62e0\u306b\u57fa\u3065\u304f\u6c7a\u5b9a\u3092\u78ba\u5b9f\u306b\u4e0b\u305b\u308b\u3088\u3046\u306b\u3057\u307e\u3059\u3002<\/li>\n<\/ul>\n<p>\u65b0\u3057\u3044\u30ac\u30a4\u30c9\u306f\u3001\u533b\u85ac\u54c1\u306e\u8ca9\u58f2\u627f\u8a8d\u30d7\u30ed\u30bb\u30b9\u3092\u8fd1\u4ee3\u5316\u304a\u3088\u3073\u5408\u7406\u5316\u3057\u3001\u898f\u5236\u4e0a\u306e\u6c7a\u5b9a\u304c\u4e00\u8cab\u6027\u3068\u900f\u660e\u6027\u3092\u4fdd\u3061\u3001\u4e16\u754c\u7684\u306a\u6163\u884c\u306b\u6cbf\u3063\u305f\u3082\u306e\u3068\u306a\u308b\u3088\u3046\u4fdd\u8a3c\u3059\u308b\u305f\u3081\u306e\u91cd\u8981\u306a\u4e00\u6b69\u3067\u3059\u3002<\/p>\n<p>\u8a73\u7d30\u3084\u304a\u554f\u3044\u5408\u308f\u305b\u306b\u3064\u304d\u307e\u3057\u3066\u306f\u3001\u5f0a\u793e\u307e\u3067\u3054\u9023\u7d61\u304f\u3060\u3055\u3044\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>On December 2, 2024, the National Directorate of Sanitary Surveillance (DINAVISA) introduced the &#8220;Guide to Good Evaluation Practices for the Registration of Medicines.&#8221; This guideline represents a major update to the regulatory framework, focusing on ensuring the quality, safety, and efficacy of pharmaceutical products through clear and transparent evaluation processes. The guide aims to align DINAVISA\u2019s procedures with international standards, fostering harmonization with global regulatory norms. It applies to all pharmaceutical products intended for human use, including drugs, biologics, chemicals, reagents, medical devices, and personal hygiene products classified as cosmetics or sanitizers. Key highlights of the guideline include: Adherence to international standards and best practices for medicinal product evaluation. Detailed&#8230;<\/p>","protected":false},"author":43,"featured_media":7926,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35,566],"tags":[496,609],"class_list":["post-7909","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","category-paraguay-regulation","tag-market-authorization-regs","tag-guideline"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Paraguay Issues New Guideline for Drug Approvals | RegASK<\/title>\n<meta name=\"description\" content=\"Paraguay\u2019s DINAVISA releases a new guideline for drug approvals, aligning with global standards for safety and efficacy. Read more at RegASK\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/ja\/\u30d1\u30e9\u30b0\u30a2\u30a4-\u30c7\u30a3\u30ca\u30d3\u30b5\u533b\u85ac\u54c1\u627f\u8a8d\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DINAVISA (Paraguay) Approves New Guideline for Good Evaluation Practices for Marketing Authorization\" \/>\n<meta property=\"og:description\" content=\"Paraguay\u2019s DINAVISA releases a new guideline for drug approvals, aligning with global standards for safety and efficacy. Read more at RegASK\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/ja\/\u30d1\u30e9\u30b0\u30a2\u30a4-\u30c7\u30a3\u30ca\u30d3\u30b5\u533b\u85ac\u54c1\u627f\u8a8d\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-18T10:51:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"DINAVISA (Paraguay) Approves New Guideline for Good Eva&hellip;\",\"datePublished\":\"2024-12-18T10:51:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/\"},\"wordCount\":232,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png\",\"keywords\":[\"Market authorization regs\",\"Guideline\"],\"articleSection\":[\"Pharma and Biotech\",\"Paraguay\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/\",\"name\":\"Paraguay Issues New Guideline for Drug Approvals | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png\",\"datePublished\":\"2024-12-18T10:51:47+00:00\",\"description\":\"Paraguay\u2019s DINAVISA releases a new guideline for drug approvals, aligning with global standards for safety and efficacy. Read more at RegASK\",\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/regask.com\\\/paraguay-dinavisa-drug-approval-guideline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png\",\"width\":800,\"height\":600,\"caption\":\"Dinavisa Paraguay Approves New Guideline Good Evaluation Practices Marketing Authorization\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u30d1\u30e9\u30b0\u30a2\u30a4\u3001\u533b\u85ac\u54c1\u627f\u8a8d\u306b\u95a2\u3059\u308b\u65b0\u305f\u306a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u767a\u884c | RegASK","description":"\u30d1\u30e9\u30b0\u30a2\u30a4\u306eDINAVISA\u306f\u3001\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u306b\u95a2\u3059\u308b\u4e16\u754c\u57fa\u6e96\u306b\u6cbf\u3063\u305f\u533b\u85ac\u54c1\u627f\u8a8d\u306e\u65b0\u3057\u3044\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u8a73\u7d30\u306fRegASK\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/ja\/\u30d1\u30e9\u30b0\u30a2\u30a4-\u30c7\u30a3\u30ca\u30d3\u30b5\u533b\u85ac\u54c1\u627f\u8a8d\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\/","og_locale":"ja_JP","og_type":"article","og_title":"DINAVISA (Paraguay) Approves New Guideline for Good Evaluation Practices for Marketing Authorization","og_description":"Paraguay\u2019s DINAVISA releases a new guideline for drug approvals, aligning with global standards for safety and efficacy. Read more at RegASK","og_url":"https:\/\/regask.com\/ja\/\u30d1\u30e9\u30b0\u30a2\u30a4-\u30c7\u30a3\u30ca\u30d3\u30b5\u533b\u85ac\u54c1\u627f\u8a8d\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-12-18T10:51:47+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"\u57f7\u7b46\u8005":"Reva Ananda","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/#article","isPartOf":{"@id":"https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"DINAVISA (Paraguay) Approves New Guideline for Good Eva&hellip;","datePublished":"2024-12-18T10:51:47+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/"},"wordCount":232,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png","keywords":["Market authorization regs","Guideline"],"articleSection":["Pharma and Biotech","Paraguay"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/","url":"https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/","name":"\u30d1\u30e9\u30b0\u30a2\u30a4\u3001\u533b\u85ac\u54c1\u627f\u8a8d\u306b\u95a2\u3059\u308b\u65b0\u305f\u306a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u767a\u884c | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png","datePublished":"2024-12-18T10:51:47+00:00","description":"\u30d1\u30e9\u30b0\u30a2\u30a4\u306eDINAVISA\u306f\u3001\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u306b\u95a2\u3059\u308b\u4e16\u754c\u57fa\u6e96\u306b\u6cbf\u3063\u305f\u533b\u85ac\u54c1\u627f\u8a8d\u306e\u65b0\u3057\u3044\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u8a73\u7d30\u306fRegASK\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002","inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/regask.com\/paraguay-dinavisa-drug-approval-guideline\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/dinavisa-paraguay-approves-new-guideline-good-evaluation-practices-marketing-authorization.png","width":800,"height":600,"caption":"Dinavisa Paraguay Approves New Guideline Good Evaluation Practices Marketing Authorization"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"\u9ad8\u6027\u80fd\u30c1\u30fc\u30e0\u306e\u305f\u3081\u306e\u898f\u5236AI\u30aa\u30da\u30ec\u30fc\u30c6\u30a3\u30f3\u30b0\u30b7\u30b9\u30c6\u30e0","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"\u30ec\u30f4\u30a1\u30fb\u30a2\u30ca\u30f3\u30c0"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts\/7909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/comments?post=7909"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts\/7909\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/media\/7926"}],"wp:attachment":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/media?parent=7909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/categories?post=7909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/tags?post=7909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}